Opinion|Videos|April 21, 2025
Factoring Cost, Recommendations, and Evidence Into Formulary Decisions about Lp(a) Testing
Experts discuss the cost of lipoprotein(a) (Lp[a]) tests and how these costs, along with the National Lipid Association’s (NLA) recommendation and supporting clinical evidence, may influence payer decisions regarding coverage for Lp(a) testing.
Advertisement
Video content above is prompted by the following:
- How expensive are Lp(a) tests?
- How might these costs, the NLA’s recommendation, and the supporting clinical evidence factor into payer decisions about whether to cover Lp(a) testing?
Advertisement
Related to this article
A JAMA analysis of 2021-2023 death records found heat-related mortality varied sharply by occupation and industry among working-age US adults.
Advertisement
Advertisement
Trending on AJMC
1
A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD
2
Using Complement Inhibitors in GA Comes With Pros and Cons
3
Pairing VYD2311 With mRNA COVID-19 Vaccines: Michael Mina, MD, PhD
4
New Mechanism of DME Treatment Highlights Clinical Trial Updates
5